▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1758 by analyst upside · 2026-09-27
OMDA
Omada Health, Inc.
Healthcare · Market Cap $1B · P/E 29.3x
ANALYST PRICE TARGET
+44.5%
implied upside to consensus target
Current Price $19.66
Consensus Target $28.42
Bull Target $35.0
Bear Target $22.0
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
5
Hold
2
Sell
0
52-Week Low $10.28
52-Week High $26.91
YTD Return +31.9%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 29.3x
Forward P/E 35.4x
EPS (TTM) $0.67
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $310M
Profit Margin 1.4%
52-WEEK RANGE
52-Week Low $10.28
52-Week High $26.91
Current Price $19.66
Bear Target $22.0
Bull Target $35.0
● Now $19.66 ● Target $28.42
TRADING DATA
Avg Volume 1.4M
YTD Return +31.9%
Analyst Count 12
Consensus Buy
Upside to Target +44.5%
Last Updated 2026-09-27

ANALYST SUMMARY

Omada Health, Inc. (OMDA) is currently trading at $19.66 with a Wall Street consensus price target of $28.42, implying potential upside of 44.5% over the next 12 months. 12 analysts currently cover OMDA, with a consensus rating of Buy - 83% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.0, while the most cautious has a target of $22.0.

OMDA operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 31.9% year-to-date and is currently trading near the upper end of its 52-week range of $10.28 – $26.91.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OMDA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Freedom Capital Markets - Reiterated
Buy → Buy 2026-09-14 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-09-11 Building track record
Needham reit
Buy → Buy 2026-09-11 20% win rate (5 calls)
BTIG reit
Buy → Buy 2026-09-11 38% win rate (8 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-08-14 43% win rate (7 calls)
Citizens - Reiterated
Market Outperform → Market Outperform 2026-08-14 Building track record
Baird - Reiterated
Neutral → Neutral 2026-08-12 Building track record
BTIG - Reiterated
Buy → Buy 2026-08-10 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
59
out of 100
Coverage depth
20/30
Consensus clarity
17/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →